Tovorafenib Induces Responses in Low-Grade Gliomas, Including Optic Pathway Gliomas
Tovorafenib elicited rapid, clinically meaningful tumor responses in pediatric patients with low-grade gliomas, including those with optic pathway gliomas, regardless of prior MAPK inhibitor status.
Source: onclive.com